RangaswamiJShlipakMGMathewRO, et al.The cardiovascular-kidney-metabolic health framework: implications for nephrology. Clin J Am Soc Nephrol2025; 20(9): 1299–1306.
2.
NdumeleCENeelandIJTuttleKR, et al.A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American heart association. Circulation2023; 148(20): 1636–1664.
3.
NdumeleCERangaswamiJChowSL, et al.Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association. Circulation2023; 148(20): 1606–1635.
4.
OstrominskiJWArnoldSVButlerJ, et al.Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999-2020. JAMA Cardiol2023; 8(11): 1050–1060.
5.
FerdinandKC. An overview of cardiovascular-kidney-metabolic syndrome. Am J Manag Care2024; 30(10 Suppl): S181–S188.
6.
TilgHPettaSStefanN, et al.Metabolic dysfunction-associated steatotic liver disease in adults: a review. JAMA2025; 10: 163–174.
7.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int2024; 105(4S): S117–S314.
8.
HamplSEHassinkSGSkinnerAC, et al.Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics2023; 151: e2022060640.
